Chapter/Section Purchase

1 Study Coverage
1.1 Synovial Sarcoma Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Synovial Sarcoma Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ACXT-3102
1.2.3 AL-3818
1.2.4 Axitinib
1.2.5 CMB-305
1.2.6 CUE-102
1.2.7 Others
1.3 Market by Application
1.3.1 Global Synovial Sarcoma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Synovial Sarcoma Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global Synovial Sarcoma Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global Synovial Sarcoma Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Synovial Sarcoma Treatment Sales by Region
2.4.1 Global Synovial Sarcoma Treatment Sales by Region (2017-2022)
2.4.2 Global Sales Synovial Sarcoma Treatment by Region (2023-2028)
2.5 Global Synovial Sarcoma Treatment Revenue by Region
2.5.1 Global Synovial Sarcoma Treatment Revenue by Region (2017-2022)
2.5.2 Global Synovial Sarcoma Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Synovial Sarcoma Treatment Sales by Manufacturers
3.1.1 Global Top Synovial Sarcoma Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global Synovial Sarcoma Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Synovial Sarcoma Treatment in 2021
3.2 Global Synovial Sarcoma Treatment Revenue by Manufacturers
3.2.1 Global Synovial Sarcoma Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global Synovial Sarcoma Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Synovial Sarcoma Treatment Revenue in 2021
3.3 Global Synovial Sarcoma Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Synovial Sarcoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Synovial Sarcoma Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Synovial Sarcoma Treatment Sales by Type
4.1.1 Global Synovial Sarcoma Treatment Historical Sales by Type (2017-2022)
4.1.2 Global Synovial Sarcoma Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global Synovial Sarcoma Treatment Sales Market Share by Type (2017-2028)
4.2 Global Synovial Sarcoma Treatment Revenue by Type
4.2.1 Global Synovial Sarcoma Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global Synovial Sarcoma Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global Synovial Sarcoma Treatment Revenue Market Share by Type (2017-2028)
4.3 Global Synovial Sarcoma Treatment Price by Type
4.3.1 Global Synovial Sarcoma Treatment Price by Type (2017-2022)
4.3.2 Global Synovial Sarcoma Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Synovial Sarcoma Treatment Sales by Application
5.1.1 Global Synovial Sarcoma Treatment Historical Sales by Application (2017-2022)
5.1.2 Global Synovial Sarcoma Treatment Forecasted Sales by Application (2023-2028)
5.1.3 Global Synovial Sarcoma Treatment Sales Market Share by Application (2017-2028)
5.2 Global Synovial Sarcoma Treatment Revenue by Application
5.2.1 Global Synovial Sarcoma Treatment Historical Revenue by Application (2017-2022)
5.2.2 Global Synovial Sarcoma Treatment Forecasted Revenue by Application (2023-2028)
5.2.3 Global Synovial Sarcoma Treatment Revenue Market Share by Application (2017-2028)
5.3 Global Synovial Sarcoma Treatment Price by Application
5.3.1 Global Synovial Sarcoma Treatment Price by Application (2017-2022)
5.3.2 Global Synovial Sarcoma Treatment Price Forecast by Application (2023-2028)
6 North America
6.1 North America Synovial Sarcoma Treatment Market Size by Type
6.1.1 North America Synovial Sarcoma Treatment Sales by Type (2017-2028)
6.1.2 North America Synovial Sarcoma Treatment Revenue by Type (2017-2028)
6.2 North America Synovial Sarcoma Treatment Market Size by Application
6.2.1 North America Synovial Sarcoma Treatment Sales by Application (2017-2028)
6.2.2 North America Synovial Sarcoma Treatment Revenue by Application (2017-2028)
6.3 North America Synovial Sarcoma Treatment Market Size by Country
6.3.1 North America Synovial Sarcoma Treatment Sales by Country (2017-2028)
6.3.2 North America Synovial Sarcoma Treatment Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Synovial Sarcoma Treatment Market Size by Type
7.1.1 Europe Synovial Sarcoma Treatment Sales by Type (2017-2028)
7.1.2 Europe Synovial Sarcoma Treatment Revenue by Type (2017-2028)
7.2 Europe Synovial Sarcoma Treatment Market Size by Application
7.2.1 Europe Synovial Sarcoma Treatment Sales by Application (2017-2028)
7.2.2 Europe Synovial Sarcoma Treatment Revenue by Application (2017-2028)
7.3 Europe Synovial Sarcoma Treatment Market Size by Country
7.3.1 Europe Synovial Sarcoma Treatment Sales by Country (2017-2028)
7.3.2 Europe Synovial Sarcoma Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Synovial Sarcoma Treatment Market Size by Type
8.1.1 Asia Pacific Synovial Sarcoma Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific Synovial Sarcoma Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific Synovial Sarcoma Treatment Market Size by Application
8.2.1 Asia Pacific Synovial Sarcoma Treatment Sales by Application (2017-2028)
8.2.2 Asia Pacific Synovial Sarcoma Treatment Revenue by Application (2017-2028)
8.3 Asia Pacific Synovial Sarcoma Treatment Market Size by Region
8.3.1 Asia Pacific Synovial Sarcoma Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific Synovial Sarcoma Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Synovial Sarcoma Treatment Market Size by Type
9.1.1 Latin America Synovial Sarcoma Treatment Sales by Type (2017-2028)
9.1.2 Latin America Synovial Sarcoma Treatment Revenue by Type (2017-2028)
9.2 Latin America Synovial Sarcoma Treatment Market Size by Application
9.2.1 Latin America Synovial Sarcoma Treatment Sales by Application (2017-2028)
9.2.2 Latin America Synovial Sarcoma Treatment Revenue by Application (2017-2028)
9.3 Latin America Synovial Sarcoma Treatment Market Size by Country
9.3.1 Latin America Synovial Sarcoma Treatment Sales by Country (2017-2028)
9.3.2 Latin America Synovial Sarcoma Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Synovial Sarcoma Treatment Market Size by Type
10.1.1 Middle East and Africa Synovial Sarcoma Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa Synovial Sarcoma Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa Synovial Sarcoma Treatment Market Size by Application
10.2.1 Middle East and Africa Synovial Sarcoma Treatment Sales by Application (2017-2028)
10.2.2 Middle East and Africa Synovial Sarcoma Treatment Revenue by Application (2017-2028)
10.3 Middle East and Africa Synovial Sarcoma Treatment Market Size by Country
10.3.1 Middle East and Africa Synovial Sarcoma Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa Synovial Sarcoma Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Adaptimmune Therapeutics Plc
11.1.1 Adaptimmune Therapeutics Plc Corporation Information
11.1.2 Adaptimmune Therapeutics Plc Overview
11.1.3 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Adaptimmune Therapeutics Plc Recent Developments
11.2 Advenchen Laboratories LLC
11.2.1 Advenchen Laboratories LLC Corporation Information
11.2.2 Advenchen Laboratories LLC Overview
11.2.3 Advenchen Laboratories LLC Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Advenchen Laboratories LLC Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Advenchen Laboratories LLC Recent Developments
11.3 EpiZyme Inc
11.3.1 EpiZyme Inc Corporation Information
11.3.2 EpiZyme Inc Overview
11.3.3 EpiZyme Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 EpiZyme Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 EpiZyme Inc Recent Developments
11.4 Immune Design Corp
11.4.1 Immune Design Corp Corporation Information
11.4.2 Immune Design Corp Overview
11.4.3 Immune Design Corp Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Immune Design Corp Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Immune Design Corp Recent Developments
11.5 Immunocore Ltd
11.5.1 Immunocore Ltd Corporation Information
11.5.2 Immunocore Ltd Overview
11.5.3 Immunocore Ltd Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Immunocore Ltd Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Immunocore Ltd Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Karyopharm Therapeutics Inc
11.7.1 Karyopharm Therapeutics Inc Corporation Information
11.7.2 Karyopharm Therapeutics Inc Overview
11.7.3 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Karyopharm Therapeutics Inc Recent Developments
11.8 Merck & Co Inc
11.8.1 Merck & Co Inc Corporation Information
11.8.2 Merck & Co Inc Overview
11.8.3 Merck & Co Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck & Co Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck & Co Inc Recent Developments
11.9 Millennium Pharmaceuticals Inc
11.9.1 Millennium Pharmaceuticals Inc Corporation Information
11.9.2 Millennium Pharmaceuticals Inc Overview
11.9.3 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Millennium Pharmaceuticals Inc Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Overview
11.10.3 Novartis AG Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis AG Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis AG Recent Developments
11.11 Pfizer Inc
11.11.1 Pfizer Inc Corporation Information
11.11.2 Pfizer Inc Overview
11.11.3 Pfizer Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Pfizer Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Pfizer Inc Recent Developments
11.12 Takara Bio Inc
11.12.1 Takara Bio Inc Corporation Information
11.12.2 Takara Bio Inc Overview
11.12.3 Takara Bio Inc Synovial Sarcoma Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Takara Bio Inc Synovial Sarcoma Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Takara Bio Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Synovial Sarcoma Treatment Industry Chain Analysis
12.2 Synovial Sarcoma Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Synovial Sarcoma Treatment Production Mode & Process
12.4 Synovial Sarcoma Treatment Sales and Marketing
12.4.1 Synovial Sarcoma Treatment Sales Channels
12.4.2 Synovial Sarcoma Treatment Distributors
12.5 Synovial Sarcoma Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Synovial Sarcoma Treatment Industry Trends
13.2 Synovial Sarcoma Treatment Market Drivers
13.3 Synovial Sarcoma Treatment Market Challenges
13.4 Synovial Sarcoma Treatment Market Restraints
14 Key Findings in The Global Synovial Sarcoma Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer